Schizotaxia: Current status and future directions

Current Psychiatry Reports

Volumn 5, Issue 2, 2003, Pages 128-134

  Tsuang, Ming T ^a   Stone, William S ^b   Gamma, Franziska ^b   Faraone, Stephen V ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NEUROLEPTIC AGENT; RISPERIDONE;

CLINICAL FEATURE; CLUSTER ANALYSIS; DISEASE COURSE; GENETIC PREDISPOSITION; GENETIC RISK; GLUCOSE HOMEOSTASIS; HUMAN; NEUROANATOMY; NEUROPSYCHOLOGY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTAXIA; SYMPTOMATOLOGY; BRAIN; COGNITIVE DEFECT; CONGENITAL MALFORMATION; GENETICS; METABOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION AND FORECASTING;

BRAIN; CLUSTER ANALYSIS; COGNITION DISORDERS; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; SCHIZOPHRENIA;

EID: 0142259347     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-003-0029-x     Document Type: Review

References (56)

1. Gottesman H, Erlenmeyer-Kimling L: Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-intervention in schizophrenia. Schizophr Res 2001, 51:93-102.
2. Meehl PE: Schizotaxia, schizotypy, schizophrenia. Am Psychol 1962, 17:827-838.
3. Faraone SV, Green AJ, Seidman LJ, Tsuang MT: Schizotaxia: clinical implications and new directions for research. Schizophr Bull 2001, 27:1-18.
4. Tsuang MT, Gilbertson MW, Faraone SV: Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics. In Positive vs Negative Schizophrenia. Edited by Marneros A, Tsuang MT, Andreasen N. New York: Springer-Verlag: 1991:265-291.
5. Seidman LJ, Faraone SV, Goldstein JM, et al.: Left hippocampal volume as a vulnerability indicator for schizophrenia. Arch Gen Psychiatry 2002, 59:839-849.
6. Faraone SV, Seidman LJ, Kremen WS, et al.: Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychology 1995, 104:286-304.
7. Faraone SV, Kremen WS, Lyons MJ, et al.: Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? Am J Psychiatry 1995, 152:1286-1290.
8. Battaglia M, Torgersen S: Schizotypal disorder: at the crossroads of genetics and nosology. Acta Psychiatr Scandin 1996, 94:303-310.
9. Tsuang MT, Stone WS, Tarbox SI, Faraone SV: An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophr Res 2002, 54:169-175.
10. Kendler K: Diagnostic approaches to schizotypal personality disorder: a historical perspective. Schizophr Bull 1985, 11:538-553.
11. Venables PH: Schizotypal status as a developmental stage in studies of risk for schizophrenia. In Schizotypal Personality. Edited by Raine A, Lencz T, Mednick SA. Cambridge: Cambridge University Press; 1995:107-131.
12. Torgersen S: Relationship of schizotypal personality disorder to schizophrenia: genetics. Schizophr Bull 1985, 11:554-563.
13. McGuffin P, Thapar A: The genetics of personality disorder. Br J Psychiatry 1992, 160:12-23.
14. Gunderson JG, Siever LJ, Spaulding E: The search for a schizotype: crossing the border again. Arch Gen Psychiatry 1983, 40:15-22.
15. Kendler KS, McGuire M, Gruenberg AM, Walsh D: Schizotypal symptoms and signs in the Roscommon family study. Arch Gen Psychiatry 1995, 52:296-303.
16. Grove WM, Lebow BS, Clementz BA, et al.: Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study. J Abnorm Psychol 1991, 100:15-121.
17. Kremen WS, Seidman LJ, Pepple JR, et al.: Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophr Bull 1994, 20:103-119.
18. Faraone SV, Seidman LJ, Kremen WS, et al.: Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a four-year follow-up study. J Abnorm Psychol 1999, 108:176-181.
19. Toomey R, Faraone SV, Seidman LJ, et al.: Association of vulnerability markers in relatives of schizophrenic patients. Schizophr Res 1998, 31:89-98.
20. Lyons MJ, Toomey R, Seidman LJ, et al.: Verbal learning and memory in relatives of schizophrenics: preliminary findings. Biol Psychiatry 1995, 37:750-753.
21. Faraone SV, Seidman LJ, Kremen WS, et al.: Neuropsychological functioning among the elderly nonpsychotic relatives of schizophrenic patients. Schizophr Res 1996, 21:27-31.
22. Kremen WS, Goldstein JM, Seidman LJ, et al.: Sex differences in neuropsychological function in nonpsychotic relatives of schizophrenic probands. Psychiatry Res 1997, 66:131-144.
23. Faraone SV, Seidman LJ, Kremen WS, et al.: Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry 2000, 48:120-126.
24. Gottesman H: Psychopathology through a life-span genetic prism. Am Psychol 2001, 56:864-878.
25. Tsuang MT, Faraone SV: The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 1995, 17:161-175.
26. Tsuang MT, Lyons MJ, Faraone SV: Heterogeneity of schizophrenia: conceptual models and analytic strategies. Br J Psychiatry 1990, 156:17-26.
27. Chen WJ, Liu SK, Chang CJ, et al.: Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 1998, 155:1214-1220.
28. Tsuang MT, Stone WS, Seidman LJ, et al.: Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies. Biol Psychiatry 1999, 41:1412-1418.
29. Tsuang MT, Stone WS, Tarbox SI, Faraone SV: Treatment of nonpsychotic relatives of patients with schizophrenia: a pilot study. Neuropsychiatr Genet 2003, In press.
30. Stone WS, Faraone SV, Seidman LJ, et al.: Concurrent validation of schizotaxia: a pilot study. Biol Psychiatry 2001, 50:434-440.
31. Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa; 1983.
32. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa; 1984.
33. Kendler KS, Lieberman JA, Walsh D: The structured interview for schizotypy (SIS): a preliminary report. Schizophr Bull 1989, 15:559-571.
34. Nurnberger JI, Jr., Blehar MC, Kaufmann CA, et al.: Diagnostic interview for genetic studies: rationale, unique features, and training. Arch Gen Psychiatry 1994, 51:849-859.
35. Cloninger CR, Kaufmann CA, Faraone SV, et al.: A genome-wide search for schizophrenia susceptibility loci: the NIMH genetics initiative & Millennium consortium. Am J Medi Genet 1998, 81:275-281.
36. Seidman LJ, Faraone SV, Goldstein JM, et al.: Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot MRI Study. Am J Med Genet 1997, 74:507-514.
37. Seidman LJ, Breiter HC, Goldstein JM, et al.: Functional MRI of attention in relatives of schizophrenic patients. Schizophr Res 1997, 24:172.
38. Seidman LJ, Faraone SV, Goldstein JM, et al.: Thalamic and amygdala-hippocampal volume reductions in first degree relatives of schizophrenic patients: an MRI-based morphometric analysis. Biol Psychiatry 1999, 46:941-954.
39. Faraone SV, Seidman LJ, Kremen WS, et al.: Structural brain abnormalities among relatives of patients with schizophrenia: implications for linkage studies. Schizophr Res 2003, In press.
40. Braceland FJ, Meduna LJ, Vaichulis JA: Delayed action of insulin in schizophrenia. Am J Psychiatry 1945, 102:108-110.
41. Schimmelbusch W, Mueller P, Sheps J: The positive correlation between insulin resistance and duration of hospitalization in schizophrenia. Br J Psychiatry 1971: 118:429-436.
42. Mukherjee S, Schnur DB, Reddy R: Family history of type 2 diabetes in schizophrenic patients. Lancet 1989, 4:495.
43. Popli AP, Konicki PE, Jurjus GJ, et al.: Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997, 58:108-111.
44. Hagg S, Joelsson L, Mjorndal T, et al.: Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998, 59:294-299.
45. Lindenmayer JP, Patel R: Olanzapine-induced ketoacidosis with diabetes mellitus [letter]. Am J Psychiatry 1999, 156:1471.
46. Newcomer JW, Haupt DW, Fucetola R, et al.: Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002, 59:337-345.
47. Stone WS, Faraone SV, Su J, et al.: Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. Neuropsychiatr Genet 2003, In press.
48. Cloninger CR, Kaufmann CA, Faraone SV, et al.: Genome-wide search for schizophrenia susceptibility loci: the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998, 81:275-281.
49. Hall JL, Gonder-Frederick LA, Chewning WW, et al.: Glucose enhancement of performance on memory tests in young and aged humans. Neuropsychologia 1989, 27:1129-1138.
50. Stone WS, Wenk GL, Olton DS, Gold PE: Poor blood glucose regulation predicts sleep and memory deficits in normal aged rats. J Gentrol Biol Sci 1990, 45:169-173.
51. Messier CA, Gagnon M: Effect of glucose, glucose regulation and word imagery value on human memory. Behav Neurosci 1999, 113:431-438.
52. McNay EC, Fries TM, Gold PE: Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand in a spatial task. Proc Natl Acad Sci U S A 2000, 97:2881-2885.
53. McNay EC, McCarty RC, Gold PE: Fluctuations in brain glucose concentration during behavioral testing: dissociation between brain areas and between brain and blood. Neurobiology Learning Memory 2001, 75:325-337.
54. Newcomer JW, Craft S, Fucetola R, et al.: Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr Bull 1999, 25:321-335.
55. Stone WS, Seidman LJ, Wojcik JD, Green AJ: Glucose effects on cognition in schizophrenia. Schizophr Res 2003, In press.
56. Stone WS, Tarbox SJ, Wencel H, Seidman LJ: Medial temporal lobe activation following glucose administration in schizophrenia: a fMRI study. Paper presented at the 32nd Annual Meeting of the Society for Neuroscience. Orlando, FL; November 2-7, 2002.